Herlapsa Tablet (Lapatinib)
$930.00
Herlapsa Tablet (Lapatinib) is a powerful medication used to treat a specific type of breast cancer. This tablet blocks certain proteins that cancer cells need to grow and spread, therefore, slowing down the progression of the disease. It is taken orally and should be used under the supervision of a healthcare professional. Heralapsa is available in 250mg and 100mg strengths and should only be prescribed by a qualified doctor. Order online from our reputable medical store and receive quality medication conveniently delivered to your doorstep.
Quantity
Uses of Herlapsa Tablet
Breast cancer
Benefits of Herlapsa Tablet
In Breast cancer
Herlapsa Tablet helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Herlapsa Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side effects of Herlapsa Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Herlapsa
- Abdominal pain
- Back pain
- Breathing problems
- Constipation
- Cough
- Diarrhea
- Fatigue
- Headache
- Hot flashes
- Increased bilirubin in the blood
- Insomnia (difficulty in sleeping)
- Joint pain
- Liver damage
- Loss of appetite
- Mucosal inflammation
- Nausea
- Pain in extremities
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weakness
- Weight gain
How to use Herlapsa Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Herlapsa Tablet is to be taken on an empty stomach.
How Herlapsa Tablet works
Herlapsa Tablet is an anti-cancer medication. It works against the HER2 (human epidermal growth factor receptor protein) receptors and EGFRs (epidermal growth factor receptor) which are responsible for the over-proliferation of cells. This is how it inhibits the growth of cancerous cells causing downstream signaling pathways.

.png)

